A single-arm, open-label, phase 2 study evaluating pacritinib for patients with biochemical recurrence after definitive treatment for prostate cancer: Blast study.

被引：0
|
作者：
Kilari, Deepak
Szabo, Aniko
Hall, William A.
Nelson, Ariel Ann
Johnson, Scott
Giever, Thomas A.
Burfeind, John
Tolat, Parag
Bylow, Kathryn A.
Iczkowski, Kenneth
Sun, Yunguang
Rui, Hallgeir
Thomas, James P.
Nevalainen, Marja
机构：
[1] Med Coll Wisconsin, Froedtert Canc Ctr, Dept Med, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.TPS220
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS220
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
    Shuichi Ito
    Yuya Nishiyama
    Kenkichi Sugiura
    Kazuaki Enya
    Clinical and Experimental Nephrology, 2022, 26 : 350 - 358
  • [42] BendamustinetreatmentofChinesepatientswithrelapsedindolentnon-Hodgkinlymphoma:amulticenter,open-label,single-arm,phase3study
    Shi Yuan-Kai
    Hong Xiao-Nan
    Yang Jian-Liang
    Xu Wei
    Huang Hui-Qiang
    Xiao Xiu-Bin
    Zhu Jun
    Zhou Dao-Bin
    Han Xiao-Hong
    Wu Jian-Qiu
    Zhang Ming-Zhi
    Jin Jie
    Ke Xiao-Yan
    Li Wei
    Wu De-Pei
    Yang Shen-Miao
    Du Xin
    Jia Yong-Qian
    Liu Ai-Chun
    Liu Dai-Hong
    Shen Zhi-Xiang
    Zhang Lian-Sheng
    James Leonard
    Hellriegel Edward
    中华医学杂志英文版, 2021, 134 (11) : 1299 - 1309
  • [43] An Open-Label, Single-Arm Phase Two Trial of Gefitinib in Patients With Advanced or Metastatic Castration-Resistant Prostate Cancer
    Pezaro, Carmel
    Rosenthal, Mark A.
    Gurney, Howard
    Davis, Ian D.
    Underhill, Craig
    Boyer, Michael J.
    Kotasek, Dusan
    Solomon, Benjamin
    Toner, Guy C.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (04): : 338 - 341
  • [44] A phase II open-label single-arm study of vandetanib in patients with advanced RET-rearranged non-small cell lung cancer (NSCLC): Luret study.
    Seto, Takashi
    Yoh, Kiyotaka
    Satouchi, Miyako
    Nishio, Makoto
    Yamamoto, Noboru
    Murakami, Haruyasu
    Nogami, Naoyuki
    Nosaki, Kaname
    Urata, Yoshiko
    Niho, Seiji
    Horiike, Atsushi
    Kohno, Takashi
    Matsumoto, Shingo
    Nomura, Shogo
    Kuroda, Sakiko
    Sato, Akihiro
    Ohe, Yuichiro
    Yamanaka, Takeharu
    Ohtsu, Atsushi
    Goto, Koichi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Mitoxantrone hydrochloride liposome injection in the treatment of recurrent/metastatic head and neck cancers: A multicenter, open-label, single-arm, phase Ib study.
    Yang, Hang
    Wang, Xicheng
    Zhang, Hong
    Peng, Jiyong
    Li, Weidong
    Liu, Yanyan
    Hu, Jianbing
    Zhou, Hui
    Zhang, Bing
    Liu, Jixiang
    Lin, Shunhuan
    Luo, Hao
    Hu, Jie
    Li, Zhiming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18028 - E18028
  • [46] An open-label, single-arm, phase II study evaluating the efficacy and safety of niraparib combined with radiotherapy and teriprizumab in patients with recurrent small cell lung cancer
    Zeng, W.
    Xie, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S104 - S104
  • [47] Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
    LANCET ONCOLOGY, 2023, 24 (04): : E145 - E145
  • [48] Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
    Yap, Timothy A.
    Nakagawa, Kazuhiko
    Fujimoto, Nobukazu
    Kuribayashi, Kozo
    Guren, Tormod Kyrre
    Calabro, Luana
    Shapira-Frommer, Ronnie
    Gao, Bo
    Kao, Steven
    Matos, Ignacio
    Planchard, David
    Chatterjee, Arkendu
    Jin, Fan
    Norwood, Kevin
    Kindler, Hedy L.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (06): : 613 - 621
  • [49] Venetoclax plus cytarabine and azacitidine in relapsed/refractory AML: An open-label, single-arm, phase 2 study
    You, Liangshun
    Liu, Yi
    Mai, Wenyuan
    Xie, Wanzhuo
    Zhou, De
    Mao, Liping
    Chen, Lili
    Zhou, Xinping
    Ma, Liya
    Zheng, Xiaolong
    Wei, Juying
    Lou, Yinjun
    Ye, Xingnong
    Tong, Hongyan
    Jin, Jie
    Meng, Haitao
    EUROPEAN JOURNAL OF CANCER, 2024, 202
  • [50] Everolimus for Relapsed/Refractory Classical Hodgkin Lymphoma: Multicenter, Open-Label, Single-Arm, Phase 2 Study
    Johnston, Patrick B.
    Pinter-Brown, Lauren
    Rogerio, Jaqueline
    Warsi, Ghulam
    Chau, Quincy
    Ramchandren, Radhakrishnan
    BLOOD, 2012, 120 (21)
12345